{
  "DOI": "10.1007/s10689-010-9360-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-010-9360-7",
  "alternative-id": [
    "9360"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Solyom",
      "given": "Szilvia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pylkäs",
      "given": "Katri",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Winqvist",
      "given": "Robert",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        6,
        21
      ]
    ],
    "date-time": "2010-06-21T10:47:23Z",
    "timestamp": 1277117243000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:03Z",
    "timestamp": 1559252763000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        7
      ]
    ],
    "date-time": "2023-09-07T22:41:35Z",
    "timestamp": 1694126495346
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        6,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            6,
            22
          ]
        ],
        "date-time": "2010-06-22T00:00:00Z",
        "timestamp": 1277164800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9360-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-010-9360-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9360-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "537-540",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2010,
        6,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        6,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1054/bjoc.2000.1407",
      "author": "AnglianBreastCancerStudy Group",
      "doi-asserted-by": "crossref",
      "first-page": "1301",
      "journal-title": "Br J Cancer",
      "key": "9360_CR1",
      "unstructured": "Group AnglianBreastCancerStudy (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308",
      "volume": "83",
      "year": "2000"
    },
    {
      "DOI": "10.1038/nature05887",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "1087",
      "journal-title": "Nature",
      "key": "9360_CR2",
      "unstructured": "Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093",
      "volume": "447",
      "year": "2007"
    },
    {
      "DOI": "10.1146/annurev.genet.32.1.95",
      "author": "N Rahman",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "journal-title": "Annu Rev Genet",
      "key": "9360_CR3",
      "unstructured": "Rahman N, Stratton MR (1998) The genetics of breast cancer susceptibility. Annu Rev Genet 32:95–121",
      "volume": "32",
      "year": "1998"
    },
    {
      "DOI": "10.1038/ng.2007.53",
      "author": "MR Stratton",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "journal-title": "Nat Genet",
      "key": "9360_CR4",
      "unstructured": "Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40:17–22",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMra012284",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "2339",
      "journal-title": "N Engl J Med",
      "key": "9360_CR5",
      "unstructured": "Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339–2347",
      "volume": "348",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0092-8674(01)00304-X",
      "author": "SB Cantor",
      "doi-asserted-by": "crossref",
      "first-page": "149",
      "journal-title": "Cell",
      "key": "9360_CR6",
      "unstructured": "Cantor SB, Bell DW, Ganesan S et al (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105:149–160",
      "volume": "105",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.0308717101",
      "author": "S Cantor",
      "doi-asserted-by": "crossref",
      "first-page": "2357",
      "journal-title": "Proc Natl Acad Sci",
      "key": "9360_CR7",
      "unstructured": "Cantor S, Drapkin R, Zhang F et al (2004) The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc Natl Acad Sci 101:2357–2362",
      "volume": "101",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng1902",
      "author": "S Seal",
      "doi-asserted-by": "crossref",
      "first-page": "1239",
      "journal-title": "Nat Genet",
      "key": "9360_CR8",
      "unstructured": "Seal S, Thompson D, Renwick A et al (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239–1241",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng1625",
      "author": "M Levitus",
      "doi-asserted-by": "crossref",
      "first-page": "934",
      "journal-title": "Nat Genet",
      "key": "9360_CR9",
      "unstructured": "Levitus M, Waisfisz Q, Godthelp BC et al (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37:934–935",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1624",
      "author": "O Levran",
      "doi-asserted-by": "crossref",
      "first-page": "931",
      "journal-title": "Nat Genet",
      "key": "9360_CR10",
      "unstructured": "Levran O, Attwooll C, Henry RT et al (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37:931–933",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ccr.2005.08.004",
      "author": "R Litman",
      "doi-asserted-by": "crossref",
      "first-page": "255",
      "journal-title": "Cancer Cell",
      "key": "9360_CR11",
      "unstructured": "Litman R, Peng M, Jin Z et al (2005) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8:255–265",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1073/pnas.0811159106",
      "author": "SM Sy",
      "doi-asserted-by": "crossref",
      "first-page": "7155",
      "journal-title": "Proc Natl Acad Sci",
      "key": "9360_CR12",
      "unstructured": "Sy SM, Huen MS, Chen J (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci 106:7155–7160",
      "volume": "106",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1541-7786.MCR-09-0123",
      "author": "F Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "1110",
      "journal-title": "Mol Cancer Res",
      "key": "9360_CR13",
      "unstructured": "Zhang F, Fan Q, Ren K et al (2009) PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res 7:1110–1118",
      "volume": "7",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1471-2407-8-146",
      "author": "K Pylkäs",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "BMC Cancer",
      "key": "9360_CR14",
      "unstructured": "Pylkäs K, Erkko H, Nikkilä J et al (2008) Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. BMC Cancer 8:14",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0959-8049(02)00498-7",
      "author": "SM Karppinen",
      "doi-asserted-by": "crossref",
      "first-page": "366",
      "journal-title": "Eur J Cancer",
      "key": "9360_CR15",
      "unstructured": "Karppinen SM, Vuosku J, Heikkinen K et al (2003) No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families. Eur J Cancer 39:366–371",
      "volume": "39",
      "year": "2003"
    },
    {
      "DOI": "10.1186/1471-2407-6-19",
      "author": "P Vahteristo",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "BMC Cancer",
      "key": "9360_CR16",
      "unstructured": "Vahteristo P, Yliannala K, Tamminen A et al (2006) BACH1 Ser919Pro variant and breast cancer risk. BMC Cancer 6:19",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng837",
      "author": "RI Yarden",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "journal-title": "Nat Genet",
      "key": "9360_CR17",
      "unstructured": "Yarden RI, Pardo-Reoyo S, Sgagias M et al (2002) BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30:285–289",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.dnarep.2004.03.026",
      "author": "NS Ting",
      "doi-asserted-by": "crossref",
      "first-page": "935",
      "journal-title": "DNA Repair",
      "key": "9360_CR18",
      "unstructured": "Ting NS, Lee WH (2004) The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair 3:935–944",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1038/onc.2008.17",
      "author": "EM Bahassi",
      "doi-asserted-by": "crossref",
      "first-page": "3977",
      "journal-title": "Oncogene",
      "key": "9360_CR19",
      "unstructured": "Bahassi EM, Ovesen JL, Riesenberg AL et al (2008) The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene 27:3977–3985",
      "volume": "27",
      "year": "2008"
    },
    {
      "DOI": "10.1128/MCB.02357-06",
      "author": "X Wang",
      "doi-asserted-by": "crossref",
      "first-page": "3098",
      "journal-title": "Mol Cell Biol",
      "key": "9360_CR20",
      "unstructured": "Wang X, Kennedy RD, Ray K et al (2007) Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol 27:3098–3108",
      "volume": "27",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-2312",
      "author": "G Zhi",
      "doi-asserted-by": "crossref",
      "first-page": "8775",
      "journal-title": "Cancer Res",
      "key": "9360_CR21",
      "unstructured": "Zhi G, Wilson JB, Chen X et al (2009) Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction. Cancer Res 69:8775–8783",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1093/hmg/ddm340",
      "author": "JH Guervilly",
      "doi-asserted-by": "crossref",
      "first-page": "679",
      "journal-title": "Hum Mol Genet",
      "key": "9360_CR22",
      "unstructured": "Guervilly JH, Mace-Aime G, Rosselli F (2008) Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum Mol Genet 17:679–689",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.dnarep.2009.04.012",
      "author": "TH Stracker",
      "doi-asserted-by": "crossref",
      "first-page": "1047",
      "journal-title": "DNA Repair",
      "key": "9360_CR23",
      "unstructured": "Stracker TH, Usui T, Petrini JH (2009) Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair 8:1047–1054",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ncb1555",
      "author": "SJ Collis",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "journal-title": "Nat Cell Biol",
      "key": "9360_CR24",
      "unstructured": "Collis SJ, Barber LJ, Clark AJ et al (2007) HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat Cell Biol 9:391–401",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.4161/cc.6.9.4211",
      "author": "A Efeyan",
      "doi-asserted-by": "crossref",
      "first-page": "1006",
      "journal-title": "Cell Cycle",
      "key": "9360_CR25",
      "unstructured": "Efeyan A, Serrano M (2007) P53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006–1010",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ccr.2005.01.009",
      "author": "J Puc",
      "doi-asserted-by": "crossref",
      "first-page": "193",
      "journal-title": "Cancer Cell",
      "key": "9360_CR26",
      "unstructured": "Puc J, Keniry M, Li HS et al (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7:193–204",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ejso.2007.02.007",
      "author": "CJ Kim",
      "doi-asserted-by": "crossref",
      "first-page": "580",
      "journal-title": "Eur J Surg Oncol",
      "key": "9360_CR27",
      "unstructured": "Kim CJ, Lee JH, Song JW et al (2007) Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability. Eur J Surg Oncol 33:580–585",
      "volume": "33",
      "year": "2007"
    },
    {
      "DOI": "10.1002/(SICI)1098-2264(199910)26:2\u003c176::AID-GCC11\u003e3.0.CO;2-3",
      "author": "F Bertoni",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "9360_CR28",
      "unstructured": "Bertoni F, Codegoni AM, Furlan D et al (1999) CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer 26:176–180",
      "volume": "26",
      "year": "1999"
    },
    {
      "author": "A Menoyo",
      "first-page": "7727",
      "journal-title": "Cancer Res",
      "key": "9360_CR29",
      "unstructured": "Menoyo A, Alazzouzi H, Espin E et al (2001) Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res 61:7727–7730",
      "volume": "61",
      "year": "2001"
    },
    {
      "author": "T Papp",
      "first-page": "135",
      "journal-title": "Oncol Rep",
      "key": "9360_CR30",
      "unstructured": "Papp T, Niemetz A, Dosdahl N et al (2007) Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines. Oncol Rep 17:135–140",
      "volume": "17",
      "year": "2007"
    },
    {
      "author": "K Kumar",
      "first-page": "743",
      "journal-title": "Oncol Rep",
      "key": "9360_CR31",
      "unstructured": "Kumar K, Rahman Q, Schipper H et al (2005) Mutational analysis of 9 different tumour-associated genes in human malignant mesothelioma cell lines. Oncol Rep 14:743–750",
      "volume": "14",
      "year": "2005"
    },
    {
      "author": "N Haruki",
      "first-page": "4689",
      "journal-title": "Cancer Res",
      "key": "9360_CR32",
      "unstructured": "Haruki N, Saito H, Tatematsu Y et al (2000) Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer. Cancer Res 60:4689–4692",
      "volume": "60",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s10549-006-9461-z",
      "author": "A Marsh",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9360_CR33",
      "unstructured": "Marsh A, Healey S, Lewis A et al (2007) Mutation analysis of five candidate genes in familial breast cancer. Breast Cancer Res Treat 105:377–389",
      "volume": "105",
      "year": "2007"
    },
    {
      "author": "P Vahteristo",
      "first-page": "5718",
      "journal-title": "Cancer Res",
      "key": "9360_CR34",
      "unstructured": "Vahteristo P, Tamminen A, Karvinen P et al (2001) p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718–5722",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1002/gcc.10079",
      "author": "M Allinen",
      "doi-asserted-by": "crossref",
      "first-page": "384",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "9360_CR35",
      "unstructured": "Allinen M, Peri L, Kujala S et al (2002) Analysis of 11q21–24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 34:384–389",
      "volume": "34",
      "year": "2002"
    },
    {
      "DOI": "10.1101/gr.080259.108",
      "author": "OA Hampton",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "journal-title": "Genome Res",
      "key": "9360_CR36",
      "unstructured": "Hampton OA, Den Hollander P, Miller CA et al (2009) A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 19:167–177",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-009-0428-8",
      "author": "N Ameziane",
      "doi-asserted-by": "crossref",
      "first-page": "651",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9360_CR37",
      "unstructured": "Ameziane N, van den Ouweland AM, Adank MA et al (2009) Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer. Breast Cancer Res Treat 118:651–653",
      "volume": "118",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.295.12.1379",
      "author": "T Walsh",
      "doi-asserted-by": "crossref",
      "first-page": "1379",
      "journal-title": "JAMA",
      "key": "9360_CR38",
      "unstructured": "Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379–1388",
      "volume": "295",
      "year": "2006"
    }
  ],
  "reference-count": 38,
  "references-count": 38,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-010-9360-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families"
  ],
  "type": "journal-article",
  "volume": "9"
}